Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2026-03-02 @ 5:52 PM
Study NCT ID:
NCT04253561
Status:
UNKNOWN
Last Update Posted:
2023-04-18
First Post:
2020-01-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients
Sponsor:
SOLTI Breast Cancer Research Group
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Metastatic Breast Cancer | View |
Keywords: